Clinical Trial Update: Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor [Phase 4]

View source ↗

Summary

Phase 4 trial investigating dexmedetomidine to prevent postoperative delirium after intracranial tumor surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Diseases

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Capital Medical University | Conditions: Central Nervous System Diseases | Phase 4 | Status: UNKNOWN